4DX 2.86% 54.0¢ 4dmedical limited

Ann: 1H FY2024 Investor Presentation, page-7

  1. 1,490 Posts.
    lightbulb Created with Sketch. 588
    xmlmillr6 (tga.gov.au)

    xmlmillr6 (tga.gov.au)

    Looks like Imbio received TGA approvals in late calendar year 2021 for their Lung Density Analysis (LDA) and Lung Texture Analysis (LTA) products, but probably never got around to commercialising it in Australia - presumably due to competing demands for capital. 4DX has the know-how and networks to get this to market quickly (synergies) - with all their learnings to date and existing contracts.

    What's interesting is the LTA which yesterday was announced will be used by the VA in the context of lung cancer screening. Well, in Australia, we've got the lung cancer screening funded and due to start in the near future. We can sell this to the govt as an additional tool in the screening process along with our XV technology - to give a comprehensive picture of the patient's lungs.
 
watchlist Created with Sketch. Add 4DX (ASX) to my watchlist
(20min delay)
Last
54.0¢
Change
0.015(2.86%)
Mkt cap ! $221.6M
Open High Low Value Volume
53.0¢ 54.0¢ 51.5¢ $226.9K 431.3K

Buyers (Bids)

No. Vol. Price($)
1 16886 54.0¢
 

Sellers (Offers)

Price($) Vol. No.
54.5¢ 41547 4
View Market Depth
Last trade - 16.10pm 17/07/2024 (20 minute delay) ?
4DX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.